Barclays Maintains Overweight on Marathon Oil, Lowers Price Target to $34
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Betty Jiang maintains an Overweight rating on Marathon Oil (NYSE:MRO) but lowers the price target from $35 to $34.

October 03, 2024 | 3:36 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Barclays has maintained its Overweight rating on Marathon Oil but slightly reduced the price target from $35 to $34, indicating a minor adjustment in expectations.
The Overweight rating suggests continued confidence in Marathon Oil's performance, but the slight reduction in the price target indicates a minor adjustment in expectations. This is likely to have a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100